HomeAsian NewsThe third wave of COVID-19 may peak in October: NIDM report

The third wave of COVID-19 may peak in October: NIDM report


There is no biological evidence that the current and new Delta Plus variants affect children more than adults

New Delhi: The National Institute of Disaster Management (NIDM) under the Ministry of the Interior warned in a recent report to the Prime Minister’s Office that there will be a third COVID-19 peak in October.

The NIDM report cited a Reuters survey of 40 experts, which predicted that the third wave of the COVID-19 pandemic is likely to hit India between July 15 and October 13, 2021.

Regarding whether Delta-Plus Variant will become the driving factor of the third wave, NIDM stated that the Delta-Plus variant was formed due to the mutation of B.1.617.2 (Delta variant), which promoted India’s deadly second time. Surge. This worrying new variant is a subline of the Delta variant, which acquired the spike protein mutation “K417N”, which was also found in the Beta variant (first detected in South Africa).

“Although there is not enough evidence that the Delta Plus variant is more dangerous than Delta, according to NCDC, as of August 2, 2021, the variant has been detected in 58,240 samples in 16 states so far. India did the sequencing,” it said.

The report highlights the potential impact of the third wave of COVID on children, saying that the Indian Academy of Pediatrics has found that there is no biological evidence that the current and new Delta Plus variants affect children more than adults.

The report further stated that the Indian Working Group of the Lancet COVID-19 Committee concluded that there is currently no evidence that the expected third wave will specifically target children.

“A serological survey conducted by the All India Institute of Medical Sciences (AIIMS) (from March 15 to June 10, 2021, more than 45,000 samples in 4 states were surveyed) shows that the next wave is specifically aimed at children The hypothesis (two years and older) is unfounded. The study pointed out that the serological prevalence rate of 2-17 years old is 55.7% and that of adults is 63.5%, which clearly shows that there is a statistical difference in prevalence between adults and children. “The report mentioned.



Source link

RELATED ARTICLES

Most Popular

Recent Comments